… Although the most obvious changes in the 8th edition are in the N (ie perivesical lymph
node involvement now classified as N1) and M (ie M1 is subdivided into M1a and M1b) …

Background and Aims The EpiCom study and inception cohort was initiated in 2010 in 31
centers from 14 Western and 8 Eastern European countries, covering a 10.1 million person …

Background and Aims The incidence of inflammatory bowel disease (IBD) is increasing in
Eastern Europe possibly due to changes in environmental factors towards a more “westernised…

Background and aims: The aim of the present study was to validate the IBD (inflammatory
bowel diseases) incidence reported in the 2010 ECCO-EpiCom (European Crohn's and Colitis …

Background & Aims Health-related quality of life (HRQoL) is impaired in patients with Inflammatory
Bowel Disease (IBD). The aim was prospectively to assess and validate the pattern of …

Objective The incidence of inflammatory bowel disease (IBD) is increasing in Eastern Europe.
The reasons for these changes remain unknown. The aim of this study was to investigate …

Objective To examine differences in disease progression and nature of tumor invasion that
may lead to more accurate expectations of tumor behavior and improved management …

Objectives To evaluate pathologic and survival outcomes among patients with variant
histology (VH) urothelial carcinoma of the bladder. Methods A retrospective review of an …

Objectives Plasmacytoid variant (PCV) urothelial cancer (UC) of the bladder is rare, with poor
clinical outcomes. We sought to identify factors that may better inform expectations of tumor …

This work identifies a critical mechanism for APE1/Ref-1 in bladder cancer growth and provides
compelling preclinical data using selective redox activity inhibitors of APE1/Ref-1 in vitro …